End-Of-Radiation PSA as a Novel Prognostic Factor in Patients Undergoing Definitive Radiation and Androgen Deprivation Therapy for Prostate Cancer
Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/pcan.2016.67
Full Text
Open PDFAbstract
Available in full text
Date
January 17, 2017
Authors
Publisher
Springer Science and Business Media LLC